Back to shop

PROSOLV® 730

Prosolve 730_JRS Pharma

€0.00

Clear
Total:

Description

Directly Compressible Carrier for Lipophilic Ingredients – The next Generation of High Functionality Excipients

The newest innovation in high functionality excipients, PROSOLV® 730, was developed to provide solutions to challenges presented by oily active ingredients and poorly water-soluble, lipophilic substances.

PROSOLV® 730 is a co-processed composite consisting of microcrystalline cellulose, silicon dioxide, and copovidone. Each component is regarded as safe for nutraceutical applications and complies with the corresponding monographs of the Ph. Eur and USP/NF.

PROSOLV® 730 is now available in specific markets, including North America and parts of Europe, and will be globally available in 2023.

Additional information

Manufacturer

JRS Pharma
Quality

Ph. Eur, USP/NF
Composition

co-processed composite consisting of microcrystalline cellulose, silicon dioxide, and copovidone
Function

provide solutions to challenges presented by oily active ingredients and poorly water-soluble, lipophilic substances

Documents and Links

You may also like…

PROSOLV® SMCC HD 90

€0.00 		JRS Pharma Select options

PROSOLV® SMCC 50

€0.00 		JRS Pharma Select options